165 related articles for article (PubMed ID: 10221612)
1. Conservative treatment of adenocarcinoma of the endometrium in young patients. Is it appropriate?
Vinker S; Shani A; Open M; Fenig E; Dgani R
Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):63-5. PubMed ID: 10221612
[TBL] [Abstract][Full Text] [Related]
2. Endometrial carcinoma in a young patient with polycystic ovarian syndrome: first suspected at time of embryo transfer.
Salha O; Martin-Hirsch P; Lane G; Sharma V
Hum Reprod; 1997 May; 12(5):959-62. PubMed ID: 9194647
[TBL] [Abstract][Full Text] [Related]
3. [Endometrial cancer in young patients: report of 17 cases].
Dudnyikova A; Horváth K; Pete I
Magy Onkol; 2013 Sep; 57(3):203-6. PubMed ID: 24107826
[TBL] [Abstract][Full Text] [Related]
4. Endometrial carcinoma remaining after term pregnancy following conservative treatment with medroxyprogesterone acetate.
Mitsushita J; Toki T; Kato K; Fujii S; Konishi I
Gynecol Oncol; 2000 Oct; 79(1):129-32. PubMed ID: 11006045
[TBL] [Abstract][Full Text] [Related]
5. Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations.
Imai M; Jobo T; Sato R; Kawaguchi M; Kuramoto H
Eur J Gynaecol Oncol; 2001; 22(3):217-20. PubMed ID: 11501776
[TBL] [Abstract][Full Text] [Related]
6. Unsuspected uterine carcinosarcoma (heterologous) diagnosed following conservative therapies with medroxyprogesterone acetate for presumed early-stage endometrial carcinoma.
Fujiwara H; Shibahara H; Usui R; Takamizawa S; Kosuge S; Ohwada M; Suzuki M; Sato I
Am J Reprod Immunol; 2002 Mar; 47(3):129-31. PubMed ID: 12069197
[No Abstract] [Full Text] [Related]
7. Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.
Kaku T; Yoshikawa H; Tsuda H; Sakamoto A; Fukunaga M; Kuwabara Y; Hataeg M; Kodama S; Kuzuya K; Sato S; Nishimura T; Hiura M; Nakano H; Iwasaka T; Miyazaki K; Kamura T
Cancer Lett; 2001 Jun; 167(1):39-48. PubMed ID: 11323097
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of conservative therapy for young women with early endometrial adenocarcinoma.
Mao Y; Wan X; Chen Y; Lv W; Xie X
Fertil Steril; 2010 Jan; 93(1):283-5. PubMed ID: 19962142
[TBL] [Abstract][Full Text] [Related]
9. Sparing fertility in young patients with endometrial cancer.
Chiva L; Lapuente F; González-Cortijo L; Carballo N; García JF; Rojo A; Gonzalez-Martín A
Gynecol Oncol; 2008 Nov; 111(2 Suppl):S101-4. PubMed ID: 18804267
[TBL] [Abstract][Full Text] [Related]
10. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
Hurst SA; Hartzfeld KM; Del Priore G
Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger.
Ota T; Yoshida M; Kimura M; Kinoshita K
Int J Gynecol Cancer; 2005; 15(4):657-62. PubMed ID: 16014120
[TBL] [Abstract][Full Text] [Related]
12. Primary hormonal treatment for early endometrial carcinoma.
Sardi J; Anchezar Henry JP; Paniceres G; Gomez Rueda N; Vighi S
Eur J Gynaecol Oncol; 1998; 19(6):565-8. PubMed ID: 10215442
[TBL] [Abstract][Full Text] [Related]
13. Conservative management of endometrial cancer: a survey amongst European clinicians.
La Russa M; Zapardiel I; Halaska MJ; Zalewski K; Laky R; Dursun P; Lindquist D; Sukhin V; Polterauer S; Biliatis I
Arch Gynecol Obstet; 2018 Aug; 298(2):373-380. PubMed ID: 29943129
[TBL] [Abstract][Full Text] [Related]
14. Successful pregnancy after conservative surgery for stage IA endometrial cancer in a young woman.
Yasuda M; Terai Y; Sekijima T; Sasaki H; Yamashita Y; Kanemura M; Ohmichi M
Fertil Steril; 2009 Mar; 91(3):936.e13-5. PubMed ID: 19062001
[TBL] [Abstract][Full Text] [Related]
15. Endometrial adenocarcinoma in early pregnancy.
Kovács AG; Cserni G
Gynecol Obstet Invest; 1996; 41(1):70-2. PubMed ID: 8821890
[TBL] [Abstract][Full Text] [Related]
16. Assisted reproductive technologies in conjunction with conservatively treated endometrial adenocarcinoma. A case report.
Ogawa S; Koike T; Shibahara H; Ohwada M; Suzuki M; Araki S; Sato I
Gynecol Obstet Invest; 2001; 51(3):214-6. PubMed ID: 11306913
[TBL] [Abstract][Full Text] [Related]
17. The nuclear channel system in endometrial adenocarcinoma exposed to medroxyprogesterone acetate.
Horbelt DV; Delmore JE; Parmley TH; Roberts DK; Walker N
Hum Pathol; 1996 Jan; 27(1):9-14. PubMed ID: 8543319
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
[TBL] [Abstract][Full Text] [Related]
19. Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium.
Minaguchi T; Nakagawa S; Takazawa Y; Nei T; Horie K; Fujiwara T; Osuga Y; Yasugi T; Kugu K; Yano T; Yoshikawa H; Taketani Y
Cancer Lett; 2007 Apr; 248(1):112-22. PubMed ID: 16919866
[TBL] [Abstract][Full Text] [Related]
20. [Hormonal therapy in the treatment of endometrial adenocarcinoma].
Rob L
Ceska Gynekol; 1996 Aug; 61(4):249-50. PubMed ID: 8963496
[No Abstract] [Full Text] [Related]
[Next] [New Search]